AZD1390
目录号: A16798
ATM 抑制剂
AZD1390 是一种首创的口服可用且能穿透中枢神经系统(CNS)的 ATM 抑制剂,在细胞中的 IC50 为 0.78 nM,对于 PIKK 酶家族中的其他密切相关成员具有超过 10,000 倍的选择性,并且在广泛的激酶组中表现出极佳的选择性。
| Discription | AZD1390 is a first-in-class orally available and CNS penetrant ATM inhibitor with an IC50 of 0.78 nM in cells and >10,000-fold selectivity over closely related members of the PIKK family of enzymes and excellent selectivity across a broad panel of kinases. | |||||
|---|---|---|---|---|---|---|
| Targets |
|
|||||
| Cell Research |
|
| 目录号 | A16798 |
|---|---|
| 分子式 | C27H32FN5O2 |
| 分子量 | 477.57 |
| CAS号 | 2089288-03-7 |
| SMILES | O=C(N1C(C)C)N(C)C2=C1C3=CC(C4=CC=C(OCCCN5CCCCC5)N=C4)=C(F)C=C3N=C2 |
| 其他名称 | AZD-1390, AZD 1390 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 14 mg/mL (29.31 mM) | |
| Water | Insoluble | ||
| Ethanol | 93 mg/mL (194.73 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 20.94 mL | 104.7 mL | 209.39 mL |
| 0.5 mM | 4.19 mL | 20.94 mL | 41.88 mL |
| 1 mM | 2.09 mL | 10.47 mL | 20.94 mL |
| 5 mM | 0.42 mL | 2.09 mL | 4.19 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2